Brief: Eagle Pharmaceuticals Reaches Settlement Agreement With Hospira Related To Bendeka (Bendamustine Hydrochloride) Until January 17, 2028
19/04/2022 11:51
April 19 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS REACHES SETTLEMENT AGREEMENT WITH
HOSPIRA
RELATED TO BENDEKA® (BENDAMUSTINE HYDROCHLORIDE) UNTIL JANUARY
17, 2028
* EAGLE PHARMACEUTICALS INC - SETTLEMENT AGREEMENT IS
CONFIDENTIAL
Source text for Eikon: ID:nGNX90cQJ5
Further company coverage: EGRX.O
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq